ETF Holdings Breakdown of SCLX

Stock NameScilex Holding Company
TickerSCLX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS80880W1062

News associated with SCLX

FDA Grants Scilex Holding Orphan Drug Status For Colchicine To Treat Pericarditis
(RTTNews) - Scilex Holding Co. (SCLX) announced that FDA has approved it request for the Orphan drug designation for colchicine for the treatment of pericarditis. - 2025-04-17 03:40:01
Scilex (NASDAQ:SCLX) Shares Up 1.8% – Still a Buy?
Scilex Holding (NASDAQ:SCLX – Get Free Report)’s stock price shot up 1.8% during mid-day trading on Wednesday . The stock traded as high as $0.27 and last traded at $0.25. 937,881 shares changed hands during mid-day trading, a decline of 34% from the average session volume of 1,413,339 shares. The stock had previously closed at […] - 2025-03-27 07:06:44

SCLX institutional holdings

The following institutional investment holdings of SCLX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-14 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 904USD 4,041 6.3%
2025-06-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 321USD 1,701
Total =1,225 USD 5,742
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.